189 related articles for article (PubMed ID: 35992269)
1. Characterizing the role of SLC3A2 in the molecular landscape and immune microenvironment across human tumors.
He J; Liu D; Liu M; Tang R; Zhang D
Front Mol Biosci; 2022; 9():961410. PubMed ID: 35992269
[No Abstract] [Full Text] [Related]
2. Integrated analysis of FKBP1A/SLC3A2 axis in everolimus inducing ferroptosis of breast cancer and anti-proliferation of T lymphocyte.
Chen Z; Li R; Fang M; Wang Y; Bi A; Yang L; Song T; Li Y; Li Q; Lin B; Jia Y; Fu S; Fu S; Xiong H
Int J Med Sci; 2023; 20(8):1060-1078. PubMed ID: 37484811
[No Abstract] [Full Text] [Related]
3. Intra-Tumoral Expression of SLC7A11 Is Associated with Immune Microenvironment, Drug Resistance, and Prognosis in Cancers: A Pan-Cancer Analysis.
He J; Ding H; Li H; Pan Z; Chen Q
Front Genet; 2021; 12():770857. PubMed ID: 34938318
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of RNA-binding protein SLC3A2 regulates melanocyte ferroptosis in vitiligo by integrated analysis of single-cell and bulk RNA-sequencing.
Zhang J; Xiang F; Ding Y; Hu W; Wang H; Zhang X; Lei Z; Li T; Wang P; Kang X
BMC Genomics; 2024 Mar; 25(1):236. PubMed ID: 38438962
[TBL] [Abstract][Full Text] [Related]
6. Targeting SLC3A2 subunit of system X
Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
[TBL] [Abstract][Full Text] [Related]
7. SLC3A2 inhibits ferroptosis in laryngeal carcinoma via mTOR pathway.
Wu F; Xiong G; Chen Z; Lei C; Liu Q; Bai Y
Hereditas; 2022 Jan; 159(1):6. PubMed ID: 35057861
[TBL] [Abstract][Full Text] [Related]
8. SLC3A2 is upregulated in human osteosarcoma and promotes tumor growth through the PI3K/Akt signaling pathway.
Zhu B; Cheng D; Hou L; Zhou S; Ying T; Yang Q
Oncol Rep; 2017 May; 37(5):2575-2582. PubMed ID: 28350098
[TBL] [Abstract][Full Text] [Related]
9. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis.
Ren Z; Hu M; Wang Z; Ge J; Zhou X; Zhang G; Zheng H
Front Genet; 2021; 12():672904. PubMed ID: 34434214
[TBL] [Abstract][Full Text] [Related]
11. Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer.
Alfarsi LH; El-Ansari R; Craze ML; Masisi BK; Mohammed OJ; Ellis IO; Rakha EA; Green AR
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093034
[TBL] [Abstract][Full Text] [Related]
12. Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia.
Lin CH; Lin PP; Lin CY; Lin CH; Huang CH; Huang YJ; Lane HY
J Psychiatr Res; 2016 Jan; 72():58-63. PubMed ID: 26540405
[TBL] [Abstract][Full Text] [Related]
13. The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: A multi-omics study.
Xu F; Guan Y; Xue L; Zhang P; Li M; Gao M; Chong T
Cancer Med; 2021 Dec; 10(24):9078-9096. PubMed ID: 34761566
[TBL] [Abstract][Full Text] [Related]
14. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
15. Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer.
Gui CP; Li JY; Fu LM; Luo CG; Zhang C; Tang YM; Zhang LZ; Shu GN; Wu RP; Luo JH
J Big Data; 2022; 9(1):88. PubMed ID: 35818395
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of membranal SLC3A2 regulates the proliferation of oral squamous cancer cells and affects the prognosis of oral cancer patients.
Liang J; Sun Z
J Oral Pathol Med; 2021 Apr; 50(4):371-377. PubMed ID: 33184944
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and Immunological Role of Key Genes of Ferroptosis in Pan-Cancer.
Shi ZZ; Tao H; Fan ZW; Song SJ; Bai J
Front Cell Dev Biol; 2021; 9():748925. PubMed ID: 34722530
[TBL] [Abstract][Full Text] [Related]
18. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
Digomann D; Linge A; Dubrovska A
Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
[TBL] [Abstract][Full Text] [Related]
19. Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma.
Mou Y; Zhang L; Liu Z; Song X
BMC Cancer; 2022 Feb; 22(1):215. PubMed ID: 35227235
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 Promotes Chemoresistance to Cisplatin in Ovarian Cancer Cells by Suppressing SLC3A2.
Cui Y; Qin L; Tian D; Wang T; Fan L; Zhang P; Wang Z
Chemotherapy; 2018; 63(5):262-271. PubMed ID: 30481785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]